Ready to Participate?
Already a member?
Have a question?
Healthcare Professionals
Frequently Asked Questions about MD Analytics
MD Analytics provides market research services for the healthcare and pharmaceutical industry. We are committed to following the highest standards and care within our industry, abiding by the codes of conduct of the Canadian Research Insights Council, ESOMAR, and the Insights Association.
Why should I join the panel?
Participating in our market research studies provides opportunities for healthcare professionals to voice their opinions and inform key decisions impacting health policy and patient care. Participants also benefit from learning opportunities obtained through participating in market research and from incentives earned in exchange for their time and expert contribution.
What happens after I join?
Upon signing up to join the panel, you will be sent invitations via email to participate in online surveys, telephone interviews and/or focus groups that are relevant to your health profession and area of specialty. The study invitation will always indicate the type of study, topic, length of time required to complete the study and the incentive amount.
You decide whether a study interests you and participate as you wish. Upon completing a study, you will be paid the incentive specified.
How will my privacy be protected?
MD Analytics is committed to protecting the privacy of its research participants. When participating in our market research studies, all your responses remain anonymous and there is never any follow-up or attempt made to sell you anything.
MD Analytics is an Accredited Agency of the Canadian Research Insights Council and a member in good standing of the Insights Association. As such we are committed to going above and beyond these associations’ code of conduct, adhering to an audit every two years, to ensure we meet the highest standards.
Ready to join?
What will the content of the survey be used for and for whom?
The research sponsor and purpose will vary depending on the study. To not bias the research, we are unable to reveal their identity. However, most of our clients are multi-national pharmaceutical companies specializing in developing products and treatments for the therapeutic area of the study topic.
Are my responses anonymous?
Absolutely, your responses are anonymous. As a third-party market research firm, we never share your personal identifiable information with the research sponsor. Your responses will never be tied back to you as an individual. We always present the research findings as an aggregate between what you and your colleagues have collectively answered.
Will my name, title, or contact information be shared with research sponsors or publications?
No, we will never share that information to our clients nor any publications. If we need data from any of our physician panelists for a publication, we will state it explicitly in the first page of the survey and will ask for your consent to proceed.
How do I know if I qualify to participate?
Every online survey starts with a short eligibility section followed by the main survey. Each survey has different screening requirements, so we cannot guarantee eligibility every time. Every eligibility section will typically take from 15 seconds up to 2 minutes of your time.
What do you do with the data collected in the eligibility section?
We discard the data from the eligibility section, if you do not qualify to answer the main study questions. The data from the eligibility section is used for profiling and it is not useful for the study if it is not coupled with answers for the main survey.
How do I verify if the research is legitimate?
You can search the validity of our studies on the CRIC research verification service.
Latest Survey Data
Celebrating 20 years of MD Analytics!
We are sometimes reminded with stories, movies and books that companies have an origin too. It must have started somehow. Someone must have had a vision or an idea and then worked hard to get it going.
MD Analytics is no different in this way and its story follows its own certain path with many team members supporting the company’s growth and quality deliverables throughout the years. At the forefront is the CEO, Tyler Hassman, a fourth generation Canadian, born in Saskatchewan who migrated to British Columbia in the late 90’s; where he held several sales positions during the “dot com” days and met other ambitious soon-to-be entrepreneurs along the way. Working long hours tirelessly and then meeting with friends after work to talk about business was the way he spent most of his days. Day after day, year after year working and evolving along with the business.
In-person and remote meetings between doctors & pharma companies now standard
Since its initial onset, COVID-19 has had a significant impact on how physicians interact with pharmaceutical companies. Government restrictions forced companies to quickly adapt and move to more remote forms of interactions. While in-person interactions are once again a viable option for communication, will they return to pre-pandemic levels? MD Analytics has been monitoring these trends over the past few years and we have recently interviewed 50 Canadian GPs and 90 Canadian specialists in our latest survey on the topic.
Are remote consults here to stay?
With COVID-19 about to enter its 3rd year, it continues to significantly impact the lives of Canadians and the practices of HCPs in the country. Even though it has not been easy, physicians have continuously adapted how they manage their patients and how they interact with key healthcare stakeholders during the pandemic. MD Analytics has been monitoring these trends over the past few years and we have recently interviewed 140 physicians in our latest survey on the topic.